EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A patient‐derived orthotopic xenograft model unveils metastatic dynamics in head and neck squamous cell carcinoma

Yuchen Bai iD, Benjamin Blyth, Jarryd Boath, Qiji Deng, Ruihong Huang, Charbel Darido iD

The FEBS Journal · 2025

DOI: 10.1111/febs.70216 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Yuchen Bai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Peter MacCallum Cancer Centre, Melbourne, Australia. Hauptthemen laut MEDLINE: Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cancer Council Victoria Postdoctoral Fellowship, Peter MacCallum Cancer Foundation, Victorian Cancer Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastasis presents a significant challenge in head and neck squamous cell carcinoma (HNSC), profoundly impacting patient morbidity and mortality. This proof‐of‐concept study establishes patient‐derived orthotopic xenografts (PDOXs) as an advanced preclinical model to investigate and address metastatic HNSC. Indeed, PDOXs demonstrate noteworthy histopathological and molecular fidelity to primary HNSC tumours. Contrary to the traditional subcutaneous xenografts, PDOXs authentically replicate local lymph node metastasis, mirroring the intricate site‐specific cancer–stroma interaction and the disease progression in patients. Furthermore, genomic and transcriptomic analyses underscore the genetic accuracy and heightened resemblance of PDOXs to patient tumours. Notably, nuclear factor kappa‐B (NF‐κB)‐signalling‐induced inflammation emerges as a key driver of the metastatic process, unveiling an inflammatory signature with potential implications as a prognostic marker and therapeutic target. These findings underscore the pivotal role of the PDOX model in capturing the complex biology of HNSC, providing insights for precision‐targeted therapies and enhancing patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Squamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsHumansAnimalsMiceXenograft Model Antitumor AssaysNF-kappa BLymphatic MetastasisGene Expression Regulation, NeoplasticFemaleSignal TransductionCell Line, TumorMale

Stichwörter der Autor:innen

HNSCbiomarkersgenomicsinflammationmetastasistranscriptomicsxenograft

Substanzen

NF-kappa B

Autor:innen und Institutionen

  • Peter MacCallum Cancer Centre, Melbourne, Australia.
  • The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.

ORCID-Profile: Yuchen Bai, Charbel Darido

Förderung

  • Cancer Council Victoria Postdoctoral Fellowship
  • Peter MacCallum Cancer Foundation
  • Victorian Cancer Agency
  • Cancer Council Victoria
  • Peter MacCallum Foundation

Zitieren

APA

Bai, Y., Blyth, B., Boath, J., Deng, Q., Huang, R., & Darido, C. (2025). A patient‐derived orthotopic xenograft model unveils metastatic dynamics in head and neck squamous cell carcinoma. The FEBS Journal. https://doi.org/10.1111/febs.70216

Vancouver

Bai Y, Blyth B, Boath J, Deng Q, Huang R, Darido C. A patient‐derived orthotopic xenograft model unveils metastatic dynamics in head and neck squamous cell carcinoma. The FEBS Journal. 2025. doi:10.1111/febs.70216

BibTeX
@article{Bai2025,
  author = {Bai, Yuchen and Blyth, Benjamin and Boath, Jarryd and Deng, Qiji and Huang, Ruihong and Darido, Charbel},
  title = {A patient‐derived orthotopic xenograft model unveils metastatic dynamics in head and neck squamous cell carcinoma},
  journal = {The FEBS Journal},
  year = {2025},
  doi = {10.1111/febs.70216}
}
Kostenlos starten →